Предсердная кардиомиопатия

Понятие о предсердной кардиомиопатии — концепция, отражающая особое патофизиологическое состояние предсердий, лежащее в основе различных заболеваний. Накопление данных, свидетельствующих, что ремоделирование предсердий предшествует развитию фибрилляции предсердий, ишемического инсульта и сердечной недостаточности, позволило переосмыслить патофизиологическую роль предсердий в формировании сердечно-сосудистых заболеваний. В статье затронуты основные механизмы развития предсердной кардиомиопатии, их связь с морфологией и функцией предсердий. Анализ публикаций последних лет позволяет говорить о клинической значимости предсердной кардиомиопатии, о новых возможностях использования технологий визуализации и электрофизиологического исследования предсердий для оценки прогноза у пациентов. Поиск путей влияния на предсердную кардиомиопапию, возможно, позволит существенно улучшить исходы у пациентов с предсердными тахиаритмиями и сердечной недостаточностью.

1. Purwowiyoto S.L., Setianto B., Surya S.P. Atrial failure: what do we know about it? Acta Medica Indonesiana. 2022;54(1):131–137. https://www.actamedindones.org/index.php/ijim/article/view/1455/pdf (15.06.2025)

2. Вайханская Т.Г., Курушко Т.В., Персидских Ю.А., Сивицкая Л.Н. Предсердная кардиомиопатия — новая концепция с давней историей. Российский кардиологический журнал. 2020;25(11):143–158. DOI: 10.15829/1560-4071-2020-3942

3. Bisbal F., Baranchuk A., Braunwald E., Bayés de Luna A., BayésGenís A. Atrial failure as a clinical entity: JACC review topic of the week. Journal of the American College of Cardiology. 2020;75(2):222–232. DOI: 10.1016/j.jacc.2019.11.013

4. Pathan F., D’Elia N., Nolan M.T., Marwick T.H., Negishi K. Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. Journal of the American Society of Echocardiography. 2017;30(1):59–70. DOI: 10.1016/j.echo.2016.09.007

5. Krittanawong C., Maitra N.S., Hassan Virk H.U., Farrell A., Hamzeh I., Arya B. et al. Normal ranges of right atrial strain: a systematic review and meta-analysis. JACC Cardiovascular Imaging. 2023;16(3):282–94. DOI: 10.1016/j.jcmg.2022.06.022

6. Johnson L.S., Platonov P.G., Conen D., Kennbäck C., Jujic A., Healey J.S. et al. Markers of atrial myopathy in the general population: prevalence, predictors, and inter-relations. JACC Clinical Electrophysiology. 2023;9(11):2240–2249. DOI: 10.1016/j.jacep.2023.07.012

7. Goette A., Kalman J.M., Aguinaga L., Akar J., Cabrera J.A., Chen S.A. et al. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. Journal of Arrhythmia. 2016;32(4):247–78. DOI: 10.1016/j.joa.2016.05.002

8. Baman J.R., Cox J.L., McCarthy P.M., Kim D., Patel R.B., Passman R.S., Wilcox J.E. Atrial fibrillation and atrial cardiomyopathies. Journal of Cardiovascular Electrophysiology. 2021;32(10):2845– 2853. DOI: 10.1111/jce.15083

9. Goette A., Lendeckel U. Atrial cardiomyopathy: pathophysiology and clinical consequences. Cells. 2021;10(10). DOI: 10.3390/cells10102605

10. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., Bauer J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104(2):174–180. DOI: 10.1161/01.CIR.104.2.174

11. Rennison J.H., Li L., Lin C.R., Lovano B.S., Castel L., Wass S.Y. et al. Atrial fibrillation rhythm is associated with marked changes in metabolic and myofibrillar protein expression in left atrial appendage. Pflügers Archiv — European Journal of Physiology. 2021;473(3):461–475. DOI: 10.1007/s00424-021-02514-5

12. Enríquez-Vázquez D., Quintanilla J.G., García-Escolano A., Couselo-Seijas M., Simón-Chica A., Lee P. et al. Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value. Nature Communications. 2023;14(1):4613. DOI: 10.1038/s41467-023-40196-y

13. Silva G.M., França-Falcão M.S., Calzerra N.T.M., Luz M.S., Gadelha D.D.A., Balarini C.M., Queiroz T.M. Role of renin-angiotensin system components in atherosclerosis: focus on Ang-II, ACE2, and Ang-1–7. Frontiers in Physiology. 2020;11:1067. DOI: 10.3389/fphys.2020.01067

14. Li C.Y., Zhang J.R., Hu W.N., Li S.N. Atrial fibrosis underlying atrial fibrillation (Review). International Journal of Molecular Medicine. 2021;47(3). DOI: 10.3892/ijmm.2020.4842

15. Dilaveris P., Antoniou C.K., Manolakou P., Tsiamis E., Gatzoulis K., Tousoulis D. Biomarkers associated with atrial fibrosis and remodeling. Current Medicinal Chemistry. 2019;26(5):780–802. DOI: 10.21 74/0929867324666170918122502

16. Wang Y., Wang J., Shi L., Chen X., Li D., Cui C. et al. CIB2 Is a novel endogenous repressor of atrial remodeling. Circulation. 2023; 147(23):1758–1776. DOI: 10.1161/CIRCULATIONAHA.122.062660

17. Takahashi Y., Yamaguchi T., Otsubo T., Nakashima K., Shinzato K., Osako R. et al. Histological validation of atrial structural remodelling in patients with atrial fibrillation. European Heart Journal. 2023;44(35):3339–3353. DOI: 10.1093/eurheartj/ehad396

18. Kirchhof P., Kahr P.C., Kaese S., Piccini I., Vokshi I., Scheld H.H. et al. PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circulation Cardiovascular Genetics. 2011;4(2):123–133. DOI: 10.1161/CIRCGENETICS.110.958058

19. Chen Y.H., Xu S.J., Bendahhou S., Wang X.L., Wang Y., Xu W.Y. et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (New York, NY). 2003;299(5604):251–254. DOI: 10.1126/science.1077771

20. Qiu D., Peng L., Ghista D.N., Wong K.K.L. Left atrial remodeling mechanisms associated with atrial fibrillation. Cardiovascular Engineering and Technology. 2021;12(3):361–372. DOI: 10.1007/s13239-021-00527-w

21. Huang J.K., Lee H.C. Emerging evidence of pathological roles of very-low-density lipoprotein (VLDL). International Journal of Molecular Sciences. 2022;23(8):4300. DOI: 10.3390/ijms23084300

22. Venteclef N., Guglielmi V., Balse E., Gaborit B., Cotillard A., Atassi F. et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. European Heart Journal. 2015;36(13):795–805. DOI: 10.1093/eurheartj/eht099

23. Tubeeckx M.R.L., Laga S., Jacobs C., Stroe M., Van Cruchten S., Goovaerts B. et al. Sterile pericarditis in aachener minipigs as a model for atrial myopathy and atrial fibrillation. Journal of Visualized Experiments: JoVE. 2021(175). DOI: 10.3791/63094

24. Liao C., Akazawa H., Tamagawa M., Ito K., Yasuda N., Kudo Y. et al. Cardiac mast cells cause atrial fibrillation through PDGF-A–mediated fibrosis in pressure-overloaded mouse hearts. Journal of Clinical Investigation. 2010;120(1):242–253. DOI: 10.1172/JCI39942

25. Chen Y., Surinkaew S., Naud P., Qi X.Y., Gillis M.A., Shi Y.F., Tardif J.C., Dobrev D., Nattel S. JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrate. Cardiovascular Research. 2017;113(3):310–320. DOI: 10.1093/cvr/cvx004

26. Henderson N.C., Sethi T. The regulation of inflammation by galectin-3. Immunological Reviews. 2009;230(1):160–71. DOI: 10.1111/j.1600-065X.2009.00794.x

27. Regouski M., Galenko O., Doleac J., Olsen A.L., Jacobs V., Liechty D. et al. Spontaneous atrial fibrillation in transgenic goats with TGF (Transforming Growth Factor)-β1 induced atrial myopathy with endurance exercise. Circulation Arrhythmia and Electrophysiology. 2019;12(11):e007499. DOI: 10.1161/CIRCEP.119.007499

28. Olsen F.J., Bertelsen L., Vejlstrup N., Diederichsen S.Z., Bjerregaard C.L., Graff C. et al. Association between four-dimensional echocardiographic left atrial measures and left atrial fibrosis assessed by left atrial late gadolinium enhancement. European Heart Journal — Cardiovascular Imaging. 2022;24(1):152–161. DOI: 10.1093/ehjci/jeab275

29. Litwin S.E., Komtebedde J., Hu M., Burkhoff D., Hasenfuß G., Borlaug B.A. et al. Exercise-induced left atrial hypertension in heart failure with preserved ejection fraction. JACC Heart Failure. 2023;11(8Pt2):1103–1117. DOI: 10.1016/j.jchf.2023.01.030

30. Marwick T.H., Chandrashekhar Y. Left atrial strain: part of the solution to taming the vicious twins. JACC Cardiovascular Imaging. 2020;13(10):2278–2279. DOI: 10.1016/j.jcmg.2020.09.001

31. Dal Canto E., Remmelzwaal S., van Ballegooijen A.J., Handoko M.L., Heymans S., van Empel V. et al. Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction. Heart Failure Reviews. 2022;27(1):207–218. DOI: 10.1007/s10741-020-09985-1

32. Sun P., Cen H., Chen S., Chen X., Jiang W., Zhu H. et al. Left atrial dysfunction can independently predict exercise capacity in patients with chronic heart failure who use beta-blockers. BMC Cardiovascular Disorders. 2023;23(1):128. DOI: 10.1186/s12872-023-03127-9

33. Ovchinnikov A.G., Potekhina A., Belyavskiy E., Gvozdeva A., Ageev F. Left atrial dysfunction as the major driver of heart failure with preserved ejection fraction syndrome. Journal of Clinical Ultrasound: JCU. 2022;50(8):1073–1083. DOI: 10.1002/jcu.23318

34. Jin X., Nauta J.F., Hung C.L., Ouwerkerk W., Teng T.H.K., Voors A.A., Lam C.S., van Melle J.P. Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis. Heart Failure Reviews. 2022;27(5):1933–1955. DOI: 10.1007/s10741-02110204-8

35. Tan E.S.J., Jin X., Oon Y.Y., Chan S.P., Gong L., Lunaria J.B. et al. Prognostic value of left atrial strain in aortic stenosis: a competing risk analysis. Journal of the American Society of Echocardiography. 2023;36(1):29-37. DOI: 10.1016/j.echo.2022.10.011

36. Molnár A.Á., Sánta A., Pásztor D.T., Merkely B. Atrial cardiomyopathy in valvular heart disease: from molecular biology to clinical perspectives. Cells. 2023;12(13):1796. DOI: 10.3390/cells12131796

37. Vos J.L., Leiner T., van Dijk A.P.J., van der Zwaan H.B., Sieswerda G.T., Snijder R.J. et al. Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension. The International Journal of Cardiovascular Imaging. 2022;38(8):1699–1710. DOI: 10.1007/s10554-022-025556

38. Ling L., Kistler P.M., Ellims A.H., Iles L.M., Lee G., Hughes G.L. et al. Diffuse ventricular fibrosis in atrial fibrillation. Journal of the American College of Cardiology. 2012;60(23):2402–2408. DOI: 10.1016/j.jacc.2012.07.065

39. Bertelsen L., Diederichsen S.Z., Haugan K.J., Brandes A., Graff C., Krieger D. et al. Left atrial late gadolinium enhancement is associated with incident atrial fibrillation as detected by continuous monitoring with implantable loop recorders. JACC: Cardiovascular Imaging. 2020;13(8):1690–1700. DOI: 10.1016/j.jcmg.2020.03.024

40. Park J.J., Park J.H., Hwang I.C., Park J.B., Cho G.Y., Marwick T.H. Left Atrial strain as a predictor of new-onset atrial fibrillation in patients with heart failure. JACC: Cardiovascular Imaging. 2020;13(10):2071–2081. DOI: 10.1016/j.jcmg.2020.04.031

41. Gorcsan J. Can left atrial strain forecast future fibrillation? JACC: Cardiovascular Imaging. 2021;14(1):145–147. DOI: 10.1016/j.jcmg.2020.09.012

42. Anagnostopoulos I., Kousta M., Kossyvakis C., Paraskevaidis N.T., Schizas N., Vrachatis D., Deftereos S., Giannopoulos G. Atrial strain and occult atrial fibrillation in cryptogenic stroke patients: a systematic review and meta-analysis. Clinical Research in Cardiology: Official Journal of the German Cardiac Society. 2023;112(11):1600– 1609. DOI: 10.1007/s00392-023-02218-z

43. Pavasini R., Fabbri G., Fiorio A., Campana R., Passarini G., Verardi F.M., Contoli M., Campo G. Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease. Echocardiography (Mount Kisco, NY). 2021;38(6):909–915. DOI: 10.1111/echo.15074

44. Verbrugge F.H., Reddy Y.N.V., Attia Z.I., Friedman P.A., Noseworthy P.A., Lopez-Jimenez F., Kapa S., Borlaug B.A. Detection of left atrial myopathy using artificial intelligence-enabled electrocardiography. Circulation Heart Failure. 2022;15(1):e008176. DOI: 10.1161/CIRCHEARTFAILURE.120.008176

45. Packer M. HFpEF Is the substrate for stroke in obesity and diabetes independent of atrial fibrillation. JACC Heart Failure. 2020;8(1):35–42. DOI: 10.1016/j.jchf.2019.09.002

46. Kamel H. Does Left atrial mechanical dysfunction contribute to a thrombogenic atrial myopathy? JACC Cardiovascular Imaging. 2019;12(12):2428–2430. DOI: 10.1016/j.jcmg.2019.02.008

47. Sanna T., Diener H.C., Passman R.S., Di Lazzaro V., Bernstein R.A., Morillo C.A. et al. Cryptogenic stroke and underlying atrial fibrillation. new England Journal of Medicine. 2014;370(26):2478–2486. DOI: 10.1056/NEJMoa1313600

48. Farhat K., Elkholey K., Asad Z.U.A, Stavrakis S. Atrial myopathy and ischemic stroke in heart failure with preserved ejection fraction. The American Journal of Cardiology. 2023;203:248–252. DOI: 10.1016/j.amjcard.2023.07.058

49. Froehlich L., Meyre P., Aeschbacher S., Blum S., Djokic D., Kuehne M., Osswald S., Kaufmann B.A., Conen D. Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis. Heart. 2019;105(24):1884–1891. DOI: 10.1136/heartjnl-2019-315174

50. Guo J., Wang D., Jia J., Zhang J., Peng F., Lu J., Zhao X., Liu Y. Atrial cardiomyopathy and incident ischemic stroke risk: a systematic review and meta-analysis. Journal of Neurology. 2023;270(7):3391– 3401. DOI: 10.1007/s00415-023-11693-3

51. Papapostolou S., Kearns J., Costello B.T., O’Brien J., Rudman M., Thompson M.C., Cloud G., Stub D., Taylor A.J. Assessing atrial myopathy with cardiac magnetic resonance imaging in embolic stroke of undetermined source. International Journal of Cardiology. 2023;389:131215. DOI: 10.1016/j.ijcard.2023.131215

52. Wang W., Zhang M.J., Inciardi R.M., Norby F.L., Johansen M.C., Parikh R. et al. Association of echocardiographic measures of left atrial function and size with incident dementia. JAMA. 2022;327(12):1138. DOI: 10.1001/jama.2022.2518

53. Thiele K., Rau M., Grebe J., Korbinian Hartmann N.U., Altiok E., Böhm M. et al. Empagliflozin improves left atrial strain in patients with type 2 diabetes: data from a randomized, placebo-controlled study. Circulation Cardiovascular Imaging. 2023;16(4):e015176. DOI: 10.1161/CIRCIMAGING.122.015176

54. Mouselimis D., Tsarouchas A.S., Pagourelias E.D., Bakogiannis C., Theofilogiannakos E.K., Loutradis C., Fragakis N., Vassilikos V.P., Papadopoulos C.E. Left atrial strain, intervendor variability, and atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis. Hellenic Journal of Cardiology. 2020;61(3):154–164. DOI: 10.1016/j.hjc.2020.04.008

55. Baalman S.W.E., van den Berg N.W.E., Neefs J., Berger W.R., Meulendijks E.R., de Bruin-Bon R.H.A.C.M. et al. Left atrial strain and recurrence of atrial fibrillation after thoracoscopic surgical ablation: a subanalysis of the AFACT study. The International Journal of Cardiovascular Imaging. 2022;38(12):2615–2624. DOI: 10.1007/s10554-022-02645-5

56. Anagnostopoulos I., Kousta M., Kossyvakis C., Lakka E., Paraskevaidis N.T., Schizas N., Deftereos S., Giannopoulos G. The role of left atrial peak systolic strain in atrial fibrillation recurrence after catheter ablation. A systematic review and meta-analysis. Acta Cardiologica. 2022;77(6):536–544. DOI: 10.1080/00015385.2021.1965747

57. Sperling J.S., Delurgio D.L., Svinarich J.T. Posterior left atrial epicardial adipose tissue: scope of the problem and impact of new technology. Current Opinion in Cardiology. 2022;37(1):54–61. DOI: 10.1097/HCO.0000000000000923

58. Patel R.B., Reddy V.Y., Komtebedde J., Wegerich S.W., Sekaric J., Swarup V. et al. Atrial fibrillation burden and atrial shunt therapy in heart failure with preserved ejection fraction. JACC: Heart Failure. 2023;11(10):1351–1362. DOI: 10.1016/j.jchf.2023.05.024

59. Patel R.B., Shah S.J. Therapeutic targeting of left atrial myopathy in atrial fibrillation and heart failure with preserved ejection fraction. JAMA Cardiology. 2020;5(5):497. DOI: 10.1001/jamacardio.2020.0136

60. Deal O., Rayner J., Stracquadanio A., Wijesurendra R.S., Neubauer S., Rider O., Spartera M. Effect of weight loss on early left atrial myopathy in people with obesity but no established cardiovascular disease. Journal of the American Heart Association. 2022;11(22). DOI: 10.1161/JAHA.122.026023